Sacubitril intermediate and preparation method thereof

US10479753B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10479753-B2
Application numberUS-201816112761-A
CountryUS
Kind codeB2
Filing dateAug 26, 2018
Priority dateFeb 29, 2016
Publication dateNov 19, 2019
Grant dateNov 19, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a sacubitril intermediate and a preparation method thereof. The sacubitril intermediate disclosed herein can be prepared by a deprotection reaction of a compound. In addition, the intermediate can be used as a raw material to synthesize sacubitril. The method disclosed herein has advantages of easily obtained raw materials, simple preparation process, low cost, environment friendly, and etc., which is very suitable for industrial production.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of preparing sacubitril, comprising the following steps: a) preparing a compound of Formula (VI) by an enzymic catalytic reaction of a compound of Formula (V) in the presence of ω-transaminase and phosphopyridoxal, b) optionally, preparing a compound of Formula (VII) from the compound of Formula (VI): c) preparing sacubitril from the compound of Formula (VII), wherein: R 1 is phenyl, methoxy, hydroxy, chloro, bromo, iodo, mesylate, triflate or 4-methylbenzenesulfonate; R 2 is R 3 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl; and R 4 is H, —(C 1 -C 4 )alkyl, —(C 3 -C 6 )heterocyclyl, —(C 1 -C 4 )alkyl-aryl, trimethylsilyl, triethylsilyl or t-butyldimethylsilyl. 2. The method of claim 1 , wherein the compound of Formula (V) is prepared by a deprotection reaction of a compound of Formula (IV): in the presence of a base or an acid, wherein: R 1 is phenyl, methoxy, hydroxy, chloro, bromo, iodo, mesylate, triflate or 4-methylbenzenesulfonate; R 2 is  and when R 1 is phenyl, R 2 is not R 3 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl; R 4 is H, —(C 1 -C 4 )alkyl, —(C 3 -C 6 )heterocyclyl, —(C 1 -C 4 )alkyl-aryl, trimethylsilyl, triethylsilyl or t-butyldimethylsilyl; and R 5 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl. 3. The method of claim 2 , compound of Formula (IV) is prepared by a substitution reaction of a compound of Formula (II) with a compound of Formula (III) in the presence of a base; 4. The method of claim 3 , compound of Formula (II) is prepared by a condensation reaction of a compound of Formula (I); wherein R 1 is as defined above; and R 5 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl. 5. The method according to claim 2 , wherein the compound of the Formula (IV) is prepared by a process comprising the following steps: a) preparing a compound of Formula (II) by a condensation reaction of a compound of Formula (I) in the presence of a base, b) preparing a compound of Formula (IV) by a substitution reaction of the compound of Formula (II) with a compound of Formula (III) in the presence of a strong base; wherein R 1 is phenyl; R 2 is R 3 is H, methyl, ethyl, n-propyl, i-propyl, n-butyl, t-butyl or benzyl; R 4 is H, methyl, ethyl, n-propyl, i-propyl, n-butyl, t-butyl, benzyl, trimethylsilyl, triethylsilyl, t-butyldimethylsilyl, triphenylmethyl, tetrahydrofuryl; R 5 is H, methyl, ethyl, n-propyl, i-propyl, n-butyl or benzyl; and R 6 is triflate, mesylate or 4-methylbenzenesulfonate. 6. The method of claim 5 wherein the compound of Formula (II) is prepared by a condensation reaction of the compound of Formula (I) with N,N′-carbonyldiimidazole and a compound of Formula (VIII): in the presence of magnesium chloride and triethylamine, wherein R 5 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl. 7. The method of claim 5 , wherein the compound of Formula (II) is prepared by a condensation reaction of the compound of Formula (I) with Meldrum's acid, 4-dimethylaminopyridine, R 5 OH and pivaloyl chloride in the presence of N,N-diisopropylethylamine, R 5 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl. 8. The method of claim 1 , wherein R 1 is phenyl; R 2 is and R 3 is methyl, ethyl, propyl, i-propyl, n-butyl, t-butyl, benzyl or optionally substituted benzyl. 9. The method of claim 1 , comprising the following steps: a) preparing a compound of Formula (VII) by an enzymic catalytic reaction of a compound of Formula (V): in the presence of ω-transaminase and phosphopyridoxal; and b) preparing sacubitril by an amide condensation reaction of the compound of Formula (VII) with succinic anhydride, wherein R 1 is phenyl, and R 2 is and R 3 is ethyl. 10. The method of preparing sacubitril of claim 1 , wherein the compound of Formula (VII) is prepared by a hydrolysis reaction of the compound of Formula (VI) and then an esterification reaction of the hydrolysis product with ethanol. 11. The method of claim 1 , wherein the compound of the Formula (VII) is prepared by a process comprising the following steps: a) preparing a compound of Formula (X) by a reaction of a compound of Formula (V) with a compound of Formula (IX), b) preparing a compound of Formula (XI) from the compound of Formula (X), c) preparing a compound of Formula (XII) from the compound of Formula (XI), d) preparing a compound of Formula (VII) from the compound of Formula (XII), wherein: R 1 is phenyl, methoxy, hydroxy, chloro, bromo, iodo, mesylate, triflate or 4-methylbenzenesulfonate; R 2 is R 3 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl; and R 7 is phenyl, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl. 12. The method of claim 11 , wherein the compound of Formula (IX) in step a) is D-phenylglycinol. 13. The method of claim 11 , wherein the compound of Formula (XI) is prepared from the compound of Formula (X) in the presence of titanium tetrachloride and triethyl silicane in step b). 14. The method of claim 11 , wherein the compound of Formula (XII) is prepared from the compound of Formula (XI) in the presence of palladium-carbon in step c).

Assignees

Inventors

Classifications

  • the carbon skeleton containing rings · CPC title

  • containing six membered aromatic rings · CPC title

  • containing ether groups, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] groups · CPC title

  • containing six-membered aromatic rings · CPC title

  • Preparation of nitrogen-containing organic compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10479753B2 cover?
The present invention relates to a sacubitril intermediate and a preparation method thereof. The sacubitril intermediate disclosed herein can be prepared by a deprotection reaction of a compound. In addition, the intermediate can be used as a raw material to synthesize sacubitril. The method disclosed herein has advantages of easily obtained raw materials, simple preparation process, low cost, …
Who is the assignee on this patent?
Sunshine Lake Pharma Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07C59/205. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).